[Clinical study of the use of a new tri-phasic pill].
The paper reports the results of a study to assess the contraceptive efficacy of a new triphasic pill (Trinovum - Cilag AG). The pill was administered to 50 women aged between 18 and 41 years for 12 months, giving a total of 600 menstrual cycles. Data confirm the value of this pill which ensures excellent contraceptive efficacy and is well tolerated by patients with very few adverse effects.
Giobbe
C
C
Istituto di Ginecologia e Ostetricia, Cattedra A, Università di Torino.
Piacentino
R
R
Marchino
G L
GL
Zaccheo
F
F
Cellura
A
A
Ferrara
L
L
Mazza
O
O
Caccuri
D
D
Condello
V
V
Grio
R
R
D000293:Adolescent; D000328:Adult; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage* / Q000494:pharmacology; D004338:Drug Combinations; D004341:Drug Evaluation; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D009640:Norethindrone / Q000008:administration & dosage* / Q000494:pharmacology; D011372:Progestins / Q000008:administration & dosage / Q000494:pharmacology
D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D011372:Progestins; C020416:norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination; D004997:Ethinyl Estradiol; D009640:Norethindrone
Studio clinico sull'uso di una nuova pillola trifasica.